• SENSEX 76,738.17
    585.31 (+0.77%)
  • BANKNIFTY 57,380.60
    208.60 (+0.36%)
  • Gland Pharma
    2,826.60 1,575.00(%)
  • Tata Technolog.
    830.10 890.15(%)
  • IFCI
    103.95 101.60(%)
  • HFCL
    231.40 257.00(%)
  • Lumino Inds
    122.00 119.00(%)
  • Jindal Worldwide
    57.06 47.55(%)
  • Netweb Technol.
    5,424.00 5,810.00(%)
  • Angel One
    308.20 360.20(%)
  • HBL Engineering
    723.85 1,121.95(%)
  • Multi Comm. Exc.
    3,257.00 3,479.80(%)
  • Adani Total Gas
    620.85 859.70(%)
  • Lenskart Solut.
    694.75 680.95(%)
  • Oberoi Realty
    1,932.25 1,985.00(%)
  • RBL Bank
    413.50 410.45(%)
  • Tejas Networks
    613.50 644.75(%)
  • Polycab India
    8,308.55 6,660.50(%)
  • Antelopus Selan
    986.05 357.00(%)
  • Nuvoco Vistas
    353.50 477.35(%)
  • One 97
    1,691.50 1,732.00(%)
  • Reliance Industries
    1,332.30 1,611.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Titan Biotech Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4349.0
  • ISIN : INE150C01029
435.20 20 (4.91%)
  • As on 04 Sep 2026 (EOD)

  • Today’s Low

    420.00

  • Today’s High

    435.55

  • Open

    427.00

  • Perv Close

    414.85

  • 52W Low

    130.40

  • 52W High

    555.65

Key Indicators

  • P/E(TTM)

    58.49

  • Mar.Cap (₹Cr.)

    1,798.18

  • Div & Yield %

    0.11

  • Book Value(₹)

    41.35

  • Debt-Equity Ratio

    4.91

  • AGM Date

    03-Sep-2026

  • EPS

    7.44

  • P/E Ratio

    58.49

Financials Ratios

  • Debt-Equity Ratio

    0.07

  • Mar.Cap (₹Cr.)

    1,798.18

  • RONW (%)

    19.44

  • ROCE (%)

    24.84

Score Board

  • Equity (₹ in Cr.)

    8.26

  • BV (₹)

    41.30

  • Sales( ₹ in Cr.)

    206.19

  • NP (in Cr.)

    27.45

  • NP Var(%)

    50.0

  • Div%

    25.0

  • CPS (₹)

    7.80

  • EPS (₹)

    6.60

  • Traded Value (₹ in Lakhs)

    1,798.18

  • 52 Week High

    555.65

  • 52 Week Low

    130.40

  • Price BSE

    435.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    1,798.18

  • P/C Ratio

    55.50

  • P/E Ratio

    65.50

  • Price Vs.BV

    6.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 156.45 164.07 144.00 123.55 122.46 69.48
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 156.45 164.07 144.00 123.55 122.46 69.48
Other Income 3.91 1.75 1.94 0.94 0.75 1.02
Stock Adjustments 2.85 5.29 0.93 0.17 2.23 0.65
Total Income 163.21 171.11 146.87 124.66 125.44 71.15
EXPENDITURE :            
Raw Materials 79.34 85.33 74.61 61.64 57.58 36.75
Power and Fuel Cost 9.83 10.24 8.98 6.67 4.10 3.53
Employee Cost 26.38 23.71 18.21 14.24 11.08 9.07
Other Manufacturing Expenses 3.76 4.10 3.44 2.96 3.77 1.36
Selling and Administration Expenses 13.44 10.75 9.21 6.42 5.66 8.40
Miscellaneous Expenses 1.12 0.95 0.96 0.52 1.05 0.15
Employee Benefit Expenses 26.38 23.71 18.21 14.24 11.08 9.07
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 133.88 135.07 115.42 92.46 83.23 59.25
Operating Profit 29.34 36.03 31.47 32.21 42.20 11.90
Interest 0.80 1.17 0.75 0.87 1.33 1.91
Gross Profit 28.54 34.86 30.72 31.34 40.87 9.99
Depreciation 4.17 3.33 2.60 2.37 2.10 1.75
Profit Before Tax 24.37 31.53 28.12 28.97 38.77 8.24
Current Tax 5.97 7.76 7.18 7.35 9.86 1.85
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.12 0.11 -0.09 -0.07 0.13 0.19
Reported Net Profit 18.27 23.66 21.02 21.68 28.77 6.20
Extraordinary Items 0.00 0.00 0.00 0.00 -0.24 0.46
Adjusted Net Profit 18.27 23.66 21.02 21.68 29.01 5.74
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 111.18 89.00 69.22 48.77 20.83 14.62
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.65 1.49 1.24 1.24 0.83 0.00
P & L Balance carried down 127.80 111.18 89.00 69.22 48.77 20.83
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 20.00 20.00 18.00 15.00 15.00 10.00
Dividend Per Share(Rs) 2.00 2.00 1.80 1.50 1.50 1.00
Earnings Per Share-Unit Curr 22.11 28.64 25.44 26.24 34.82 7.50
Earnings Per Share(Adj)-Unit Curr 4.42 5.73 5.09 5.25 6.96 1.50
Book Value 175.63 155.43 128.38 104.36 79.65 45.76
Book Value(Adj)-Unit Curr 35.13 31.09 25.68 20.87 15.93 9.15

Shareholding Pattern

  • Promoter Group

    55.78%

  • Public Share Holding

    44.22%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 20,603,050 49.86 20,603,050 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,444,470 5.92 2,444,470 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 23,047,520 55.78 23,047,520 12
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,800 0.01 2,800 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,800 0.01 2,800 1
2] Non Institution
Bodies Corporate 1,395,643 3.38 1,395,643 43
Clearing Members 5,303 0.01 5,303 5
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 646,508 1.56 646,508 372
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 380,176 0.92 380,176 195
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,846,689 4.47 1,846,689 5
Individuals holding nominal share capital up to Rs. 1 lakh 9,730,085 23.55 9,730,085 18,030
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 3,931,325 9.51 3,931,325 1
Sub Total 18,268,180 44.21 18,268,180 18,658
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 41,318,500 100.00 41,318,500 18,671

Company Background

Titan Biotech LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Titan Biotech Ltd
  • BSE Code : 4349.0
  • ISIN : INE150C01029

  • Incorporation Year

    1992

  • Registered Office

    A-902 A RIICO Industrial Area
    Phase III Alwar District, Bhiwadi,
    Rajasthan-301019

  • Telephone

    91-011-27355742/27674615

  • FAX

    91-011-47619811

  • Chairman

    Rohit Jain

  • Managing Director

  • Company Secretary

    CHARANJIT SINGH

  • Auditor

    A N S K & Associates

  • Face Value

    2

  • Listing

    BSE

  • Registrar

    Beetal Fin.& Comp. Ser.(P) Ltd
    Beetal House 99,
    Madangir Behind LSC,Nr Dada Harsukhdar
    Mumbai - Delhi - 110062

Titan Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Titan Biotech 435.20 160.36 156.45 58.49 17.49
Abbott India 25,878.50 7,217.19 6,929.05 34.06 43.78
Astrazeneca Phar 6,946.95 2,304.07 2,275.58 102.39 27.86
Glaxosmi. Pharma 2,935.35 3,932.76 3,790.20 46.89 58.17
Novartis India 1,614.95 398.23 356.27 40.78 16.64
Cipla 1,389.00 20,102.60 18,979.95 36.50 13.88
Bliss GVS Pharma 636.90 773.53 729.81 59.14 12.51
Amrutanjan Healt 507.20 520.13 502.55 27.17 24.16
Fermenta Biotec. 502.80 474.15 450.25 23.47 18.77
Guj. Themis Bio. 425.00 152.47 150.80 113.64 27.21
Ambalal Sarabhai 43.88 19.52 3.94 81.26 6.77